G Marquardt1, T Niebauer, U Schick, R Lorenz. 1. Neurosurgical Clinic, Johann Wolfgang von Goethe-University, Frankfurt am Main, Germany. GMarquardt@em.uni-frankfurt.de
Abstract
OBJECTIVES: To evaluate the long term sequelae of perimesencephalic subarachnoid haemorrhage (PMSAH). METHODS: Twenty one consecutive patients were studied. All patients were examined by CT, angiography, MRI, multimodal evoked potentials, and transcranial Doppler sonography. All relevant clinical data during hospital stay and outcome at discharge were obtained by reviewing the charts. Long term follow up was evaluated by reviewing the outpatient files and dedicated outpatient review. Patients were specifically questioned about their perceived recovery, residual complaints, and present occupational status. RESULTS: Apart from the initial CT confirming the diagnosis of PMSAH all other examinations disclosed no abnormalities. None of the patients developed any complications during hospital stay, and all patients were discharged in good clinical condition and without neurological deficits. At long term follow up 62% of the patients had residual complaints consisting of headaches, irritability, depression, forgetfulness, weariness, and diminished endurance. Apart from four patients who had already retired before the PMSAH, only seven of the remaining 17 patients (41%) returned to their previous occupation, whereas nine patients (53%) retired from work and one man became unemployed. One patient had a recurrence of PMSAH 31 months after the first event. CONCLUSION: PMSAH can have considerable long term psychosocial sequelae, and may also recur. Prognosis may not be as good as previously reported.
OBJECTIVES: To evaluate the long term sequelae of perimesencephalic subarachnoid haemorrhage (PMSAH). METHODS: Twenty one consecutive patients were studied. All patients were examined by CT, angiography, MRI, multimodal evoked potentials, and transcranial Doppler sonography. All relevant clinical data during hospital stay and outcome at discharge were obtained by reviewing the charts. Long term follow up was evaluated by reviewing the outpatient files and dedicated outpatient review. Patients were specifically questioned about their perceived recovery, residual complaints, and present occupational status. RESULTS: Apart from the initial CT confirming the diagnosis of PMSAH all other examinations disclosed no abnormalities. None of the patients developed any complications during hospital stay, and all patients were discharged in good clinical condition and without neurological deficits. At long term follow up 62% of the patients had residual complaints consisting of headaches, irritability, depression, forgetfulness, weariness, and diminished endurance. Apart from four patients who had already retired before the PMSAH, only seven of the remaining 17 patients (41%) returned to their previous occupation, whereas nine patients (53%) retired from work and one man became unemployed. One patient had a recurrence of PMSAH 31 months after the first event. CONCLUSION: PMSAH can have considerable long term psychosocial sequelae, and may also recur. Prognosis may not be as good as previously reported.
Authors: A Ringelstein; O Mueller; S L Goericke; C Moenninghoff; U Sure; I Wanke; M Forsting; M Schlamann Journal: Clin Neuroradiol Date: 2013-11-28 Impact factor: 3.649
Authors: A Ringelstein; O Mueller; O Timochenko; C Moenninghoff; U Sure; M Forsting; M Schlamann Journal: Nervenarzt Date: 2013-06 Impact factor: 1.214
Authors: Liisa M Pyysalo; Tero T Niskakangas; Leo H Keski-Nisula; Veikko J Kähärä; Juha E Öhman Journal: J Neurol Neurosurg Psychiatry Date: 2011-04-06 Impact factor: 10.154
Authors: Midhun Mohan; Abdurrahman I Islim; Fahid T Rasul; Ola Rominiyi; Ruth-Mary deSouza; Michael T C Poon; Aimun A B Jamjoom; Angelos G Kolias; Julie Woodfield; Krunal Patel; Aswin Chari; Ramez Kirollos Journal: Acta Neurochir (Wien) Date: 2019-08-13 Impact factor: 2.216
Authors: Elisabeth A De Vries; Wendy Boerboom; Rita J G Van den Berg-Emons; Fop Van Kooten; Johanna M A Visser-Meily; Gerard M Ribbers; Majanka H Heijenbrok-Kal Journal: J Rehabil Med Date: 2022-05-11 Impact factor: 3.959